FDA Inspection 793023 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3004446312

The FDA completed an inspection of Aurobindo Pharma Limited on June 26, 2012 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 26, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)